| answer text |
<p>The UK is committed to rapid and equitable access to safe and effective vaccines.
The UK has been instrumental in supporting the establishment of the COVAX Facility,
the international initiative managed by Gavi, the vaccine alliance, which provides
equitable access to safe and effective vaccines for 190 economies. High and upper-middle-income
Commonwealth countries can access the self-financing window of the COVAX Facility.
Low- and middle-income Commonwealth countries are eligible for support from the COVAX
Advance Market Commitment (AMC).</p><p>The UK has committed £548 million to the COVAX
AMC, and is among its largest bilateral donors. Our commitment will contribute to
the supply of 1 billion doses in up to 92 developing countries in 2021, including
Commonwealth nations, vaccinating up to 500 million people. We work closely with COVAX
partners, such as the World Health Organisation (WHO), UNICEF, and the World Bank
to ensure that countries have the support they need to introduce COVID-19 vaccines.
The AMC aims to start deliveries in the first quarter of 2021.</p>
|
|
